Reply to: "Risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance"

被引:0
|
作者
Yip, Terry Cheuk-Fung [1 ,2 ]
Chan, Henry Lik-Yuen [1 ,2 ,3 ]
Wong, Vincent Wai-Sun [1 ,2 ,3 ]
Wong, Grace Lai-Hung [1 ,2 ,3 ]
机构
[1] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Hong Kong, Peoples R China
关键词
CARRIERS; SCORES;
D O I
10.1016/j.jhep.2017.08.026
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:208 / 209
页数:3
相关论文
共 50 条
  • [11] Development of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen
    Tong, Myron John
    Nguyen, Michael Ong
    Tong, Lori Terese
    Blatt, Lawrence Mitchell
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (08) : 889 - 893
  • [12] A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations
    Tang, Yongquan
    Chen, Yan
    Chen, Hai-Ning
    JOURNAL OF HEPATOLOGY, 2022, 77 (06) : 1722 - 1724
  • [13] Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance
    Yip, Terry Cheuk-Fung
    Chan, Henry Lik-Yuen
    Wong, Vincent Wai-Sun
    Tse, Yee-Kit
    Lam, Kelvin Long-Yan
    Wong, Grace Lai-Hung
    JOURNAL OF HEPATOLOGY, 2017, 67 (05) : 902 - 908
  • [14] Development of Hepatocellular Carcinoma after Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B
    Yoo, Sunhong
    Sohn, Won
    Park, Young Min
    Park, Sang Jong
    HEPATOLOGY, 2016, 64 : 896A - 896A
  • [15] Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen
    Yip, Terry Cheuk-Fung
    Wong, Vincent Wai-Sun
    Chan, Henry Lik-Yuen
    Tse, Yee-Kit
    Kong, Alice Pik-Shan
    Lam, Kelvin Long-Yan
    Lui, Grace Chung-Yan
    Wong, Grace Lai-Hung
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (05) : 765 - +
  • [16] Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance
    Gounder, P. P.
    Bulkow, L. R.
    Snowball, M.
    Negus, S.
    Spradling, P. R.
    Simons, B. C.
    McMahon, B. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (11) : 1197 - 1207
  • [17] A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Need a closer look!
    Lu, Wentian
    JOURNAL OF HEPATOLOGY, 2024, 80 (06) : e267 - e268
  • [18] Predictive Factors Associated with Hepatocellular Carcinoma Incidence and Mortality after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    HEPATOLOGY, 2018, 68 : 133A - 134A
  • [19] Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
    Park, Yewan
    Lee, Jeong-Hoon
    Sinn, Dong Hyun
    Park, Jun Yong
    Kim, Minseok Albert
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Kim, Do Young
    Ahn, Sang Hoon
    Kang, Wonseok
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (01)
  • [20] A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted? Reply
    Yang, Hyun
    Kim, Ji Hoon
    Han, Ji Won
    Lee, Soon Kyu
    Jang, Jeong Won
    JOURNAL OF HEPATOLOGY, 2023, 79 (04)